Clinical Trials Logo

Filter by:
NCT ID: NCT04532632 Completed - Clinical trials for Coronavirus Infection

Taste and Smell Impairment in Critically Ill COVID-19 Patients

Start date: September 1, 2020
Phase:
Study type: Observational [Patient Registry]

Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

NCT ID: NCT04532021 Active, not recruiting - Clinical trials for Preterm Premature Rupture of Membranes

Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM

MMP-14&PPROM
Start date: August 25, 2020
Phase:
Study type: Observational

Introduction: To evaluate the maternal blood serum matrix metalloproteinase 14, neopterin, and orosomucoid 1 levels in pregnant women complicated by preterm premature rupture of membranes (PPROM) and to compare the results with healthy pregnancies. In addition, to determine whether maternal/umbilical cord blood concentrations of matrix metalloproteinase 14, neopterin, and orosomucoid 1 are of value in the diagnosis of histological chorioamnionitis in patients with preterm premature rupture of membranes (PPROM). Methods: This cohort study will be included 44 pregnant women with PPROM and 44 gestational age-matched healthy subjects in 24-32 weeks of pregnancy. The blood for analysis will be firstly obtained in maternal blood on the day of diagnosis at the study group. Healthy subjects who have a normal pregnancy and outcomes without any fetal-neonatal complications will be accepted into the control group. Forty-four gestational age-matched healthy pregnant women who will be delivered at term will be included in the study as the control group. In the control group, the pregnant women will be taken the maternal blood at the admission day. The women in both groups will be observed until the delivery and perinatal data will be noted. Then, the blood for analysis will be secondly obtained in maternal blood during termination of the pregnancy (or spontaneous labor) at the study group. Lastly, the blood for analysis will be also obtained in umbilical cord blood at the study group. These three markers levels will be measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit. The placenta will be sent to histological examination in the study group. These three markers levels in women with PPROM will be compared to those of volunteer healthy pregnant women. In the study group, these three markers levels at maternal serum and cord serum will be evaluated for histological chorioamnionitis and maternal/neonatal outcomes.

NCT ID: NCT04531969 Completed - Clinical trials for Osteoarthritis, Knee

Comparison of Outpatient and Inpatient Spa Therapy

Start date: September 8, 2020
Phase: N/A
Study type: Interventional

In this study, we aimed to compare the effectiveness of inpatient and outpatient physical therapy modalities and spa combination treatments on pain and functional status in patients with knee osteoarthritis.

NCT ID: NCT04531735 Active, not recruiting - Covid19 Clinical Trials

Respiratory Syncytial Virus Infection May be More Dangerous in Neonate

Start date: March 1, 2020
Phase:
Study type: Observational

Investigators aimed to compare clinical and radiographic markers between SARS-CoV-2 positive and RSV positive infants

NCT ID: NCT04531345 Completed - Covid19 Clinical Trials

Cytokine Status of Covid-19 Patients

Start date: October 1, 2020
Phase:
Study type: Observational

COVID-19, spreading rapidly all over the world, causes serious morbidity and mortality. In severe COVID-19 infections, after pulmonary inflammation, cardiovascular organ failure, cytokine storm, hemophagocytosis, septic shock, develops due to uncontrolled hypoxia, and isolated organ failure turns into multi-organ failure. It is noteworthy that it causes lymphopenia in patients. In the studies, the blood levels of certain inflammatory cytokines, interleukin-1β,interleukin-6 and TNF-α, were evaluated. In addition, blood values of a limited number of cytokines were investigated similarly in a limited number of studies published in our country.

NCT ID: NCT04531319 Completed - Covid19 Clinical Trials

Immune Cell Subgroups in Covid 19 Patients

Start date: August 15, 2020
Phase:
Study type: Observational

COVID-19, spreading rapidly all over the world, causes serious morbidity and mortality. In severe COVID-19 infections, after pulmonary inflammation, cardiovascular organ failure, cytokine storm, hemophagocytosis, septic shock, develops due to uncontrolled hypoxia, and isolated organ failure turns into multi-organ failure. It is noteworthy that it causes lymphopenia in patients. In studies conducted, the effects of Covid-19 on the immune system were evaluated with limited parameters. In addition, no study evaluating the effect of this disease on the immune system has been published in our country.

NCT ID: NCT04529772 Active, not recruiting - Clinical trials for Diffuse Large B-Cell Lymphoma

A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)

ESCALADE
Start date: October 8, 2020
Phase: Phase 3
Study type: Interventional

Phase 3 randomized, double-blind, placebo-controlled, study assessing the efficacy and safety of acalabrutinib plus rituximab,cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) vs placebo plus R-CHOP in subjects ≤75 years of age with previously untreated non-germinal center diffuse large B-cell lymphoma.

NCT ID: NCT04529486 Completed - Cerebral Palsy Clinical Trials

Kinesio Taping in Cerebral Palsy Upper Extremity Functionality

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Purpose: The aim of this study is to investigate the effects of kinesio taping on upper extremity functionality in participants with Cerebral Palsy. Methods: This study included 14 children aged 6-16 years, diagnosed with Cerebral Palsy. The children with Cerebral Palsy were divided into 2 groups, the study group and the control group. Assessments were done three times for each group (beginning - 45min later - 1 week later). Frenchay Arm Test was used to evaluate upper extremity functionality in participants with Cerebral Palsy. Kinesio taping was applied to study group to improve posture and function in shoulder area.

NCT ID: NCT04529343 Completed - Cerebral Palsy Clinical Trials

Virtual Reality Mediated Upper Extremity rehabilitationPatients With Cerebral Palsy

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Cerebral palsy (CP) refers to a group of permanent disorders that occur in the brain of the fetus or infant, which are non-progressive, cause movement and posture disorder along with activity limitation. The upper extremity is frequently affected in patients with CP. The prevalence of upper extremity involvement has been reported between 60-83% in different studies. Virtual reality applications have been increasing recently in the field of neurological rehabilitation. In this study, researchers aimed to investigate the effectiveness of virtual reality-mediated upper extremity rehabilitation in patients with hemiplegic cerebral palsy.

NCT ID: NCT04529122 Recruiting - Solid Tumours Clinical Trials

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Start date: August 27, 2020
Phase:
Study type: Observational [Patient Registry]

WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical course of solid tumor cancers in patients who have undergone NGS testing.